Seminar - New state of the art imaging equipment at the Preclinical Imaging Facility (PIF)
Dieter Fuchs, PhD
Market Development and Preclinical Applications Manager, FUJIFILM Visualsonics, Inc.
Animal models form an essential part in many research areas such as developmental biology, cancer research, cardiology, inflammation, or virology. Therefore, state of the art in vivo imaging modalities at the Preclinical Imaging Facility (PIF) form the basis for true translational research.
This seminar will focus on the latest multimodality imaging capabilities available at the PIF, Vevo LAZR-X, which covering non-invasive and pain free applications for early detection, sizing, volumetric quantification, dynamic imaging, hypoxia assessment, etc. in arious animal models with an outlook to clinical use.
Dieter Fuchs is responsible for preclinical applications and market development for Fujifilm VisualSonics. Prior to joining Fujifilm VisualSonics Dieter received his PhD at the University of Uppsala in 2009 and held a post doctoral position at the Karolinska Institut, working on preclincial models for childhood cancer.